IMM-6-415 is under clinical development by Immuneering and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR ...

The Archer AXE75 is not only an excellent Wi-Fi 6 router, but it also adds support for 6GHz transmissions known as Wi-Fi 6E, making it one of the most cutting-edge, too. Being able to future-proof ...

IMM-6-415 is an oral, twice-daily Deep Cyclic Inhibitor currently in a Phase 1/2a trial in patients with advanced solid tumors harboring RAS or RAF mutations. The company’s development pipeline ...

Key stat: Dayton made 2 of 9 3-pointers. UNLV made 2 of 7. Big runs: Dayton had a 6-0 run to take its biggest lead, 22-14, with 8 minutes, 4 seconds left in the half. UNLV answered that run with ...

The excitement tips off at 6:30 PM ET when the DePaul Blue Demons go head-to-head with the St. John’s Red Storm. At 7:00 PM it’s UNLV vs Dayton at UD Arena. The action continues at 7:30 PM with a ...

s Phase 1/2a trial of IMM-6-415. Details of how to access the Investor Event will be provided in due course. “We are excited to soon share additional data from our Phase 2a study of IMM-1-104 in ...

PD and safety data from the Phase 1 portion of the company’s Phase 1/2a trial of IMM-6-415. Details of how to access the Investor Event will be provided in due course.

God calls everyone to work to make the world a better place. There are a LOT of ways to do this. Check out SERVICE Saturdays, the REAL Dayton, BreakOut trips, Table of Plenty, Summer Immersion trips ...

In addition, the company will provide initial PK, PD and safety data from the Phase 1 portion of the company's Phase 1/2a trial of IMM-6-415. Details of how to access the Investor Event will be ...

PD and safety data from the Phase 1 portion of the company's Phase 1/2a trial of IMM-6-415. Details of how to access the Investor Event will be provided in due course. Get the latest news delivered to ...